OSUR - OraSure Technologies' subsidiary Diversigen launches metatranscriptomic sequencing and analysis services for gut microbiome sampleshe

OraSure Technologies (NASDAQ:OSUR) Diversigen subsidiary has launched a new service to provide metatranscriptomic sequencing and analysis of gut microbiome samples. The metatranscriptomic services will generate a microbial community’s gene expression profile to inform customers about the interactions between an individual and their microbiome and will provide a holistic picture of a sample’s microbial functions and expression levels. Researchers in the pharmaceutical, biotechnical, academic, and consumer products fields are the anticipated customers for these new services.

For further details see:

OraSure Technologies’ subsidiary Diversigen launches metatranscriptomic sequencing and analysis services for gut microbiome sampleshe